After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

In 2023, roughly 7% of adults 65 and older reported using cannabis, according to an analysis published by JAMA Internal ...

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) will host its inaugural 2025 R&D Day today to highlight its key pipeline programs and their potential to drive long-term growth.

Industry veteran Catherine Owen Adams expects external innovation will be key to getting the brain-focused drug developer to “the next level.” ...

The brain drug developer is now saying that its two marketed products could ultimately bring in $2 billion annually, and its ...

Alzheimer’s is more than memory loss. Discover early symptoms like mood shifts, personality changes, and why it’s often ...

Looking after caregivers' health and early education will ensure more people can be cared for in the community. Read more at ...

Charlie Health reports rising temperatures worsen mental health, increasing risk of anxiety, depression, and suicide, ...

Last year's estimates suggest that as many as 1.1 million eligible people are missing out on Attendance Allowance support.

County deputies arrested an Above the Rest Residential Care employee. SC Department of Public Health reports detail incidents ...

A new study analyzing data from millions of patients shows significant links between cannabis use and major adverse ...